Skip to main content
MASIMO CORP logo

MASIMO CORP — Investor Relations & Filings

Ticker · MASI ISIN · US5747951003 LEI · 549300Q4A8JK0PIYCU29 US Manufacturing
Open in API
Filings indexed 1,253 across all filing types
Latest filing 2019-02-26 Regulatory Filings
Country US United States of America
Listing US MASI

About MASIMO CORP

https://www.masimo.com/

Masimo is a global medical technology company that develops, manufactures, and markets a wide array of noninvasive patient monitoring technologies. The company's core offering is its proprietary Signal Extraction Technology (SET®) pulse oximetry, renowned for its ability to provide accurate measurements during patient motion and low peripheral perfusion. Masimo's product portfolio also includes advanced solutions for brain function monitoring (SedLine®), regional oximetry (O3®), and integrated patient monitoring and connectivity platforms like Root®. These technologies are designed to improve patient outcomes, enhance patient safety, and streamline clinical workflows in various healthcare settings, including hospitals, emergency medical services, and home care. The company focuses on creating innovative solutions that empower clinicians with reliable data to make critical care decisions.

Recent filings

Filing Released Lang Actions
POSASR
Regulatory Filings Classification · 100% confidence The document is a Post-Effective Amendment No. 1 to a Form S-3ASR Registration Statement filed with the SEC. It deregisters all unsold securities previously registered under the prior registration statement. The content focuses on deregistration of securities and termination of the prior registration statement's effectiveness. This is a regulatory filing related to securities registration and deregistration, not a financial report, earnings release, or other report types. It fits best under Regulatory Filings (RNS) as it is a compliance document related to SEC registration statements and amendments.
2019-02-26 English
10-K
Annual Report FY 2018
2019-02-26 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K current report filed with the SEC by Masimo Corporation. It announces the issuance of a press release reporting the financial results for the quarter and full year ended December 29, 2018, and references supplemental financial information and a conference call. The document itself is an announcement of financial results and related materials, not the full earnings release or detailed financial report. The presence of a press release and supplemental presentation as exhibits confirms this is a current report announcing earnings results rather than the earnings release itself. Therefore, the document fits the category of Earnings Release (ER) as it is the initial announcement of quarterly/periodical financial results with key highlights.
2019-02-26 English
FORM 4
Director's Dealing
2019-02-21 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-02-13 English
SC 13G/A-2018
Major Shareholding Notification
2019-02-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.